Colonic adenocarcinomas rapidly induced by the combined treatment with 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and dextran sodium sulfate in male ICR mice possess β-catenin gene mutations and increases immunoreactivity for β-catenin, cyclooxygenase-2 and inducible nitric oxide synthase

Carcinogenesis

Volumn 26, Issue 1, 2005, Pages 229-238

  Tanaka, Takuji ^a   Suzuki, Rikako ^a,b   Kohno, Hiroyuki ^a   Sugie, Shigeyuki ^a   Takahashi, Mami ^c   Wakabayashi, Keiji ^c  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; 2 AMINO 3,8 DIMETHYLIMIDAZO[4,5 F]QUINOXALINE; BETA CATENIN; CYCLOOXYGENASE 2; DRINKING WATER; INDUCIBLE NITRIC OXIDE SYNTHASE; SODIUM SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CARCINOGEN DNA INTERACTION; COLON ADENOCARCINOMA; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; DYSPLASIA; ENVIRONMENTAL FACTOR; GENE INTERACTION; GENE MUTATION; GENE SEQUENCE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADENOCARCINOMA; ANIMALS; ANTICOAGULANTS; BASE SEQUENCE; BETA CATENIN; CARCINOGENS; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; CYTOSKELETAL PROTEINS; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; IMIDAZOLES; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED ICR; MUTATION; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; QUINOXALINES; RESTRICTION MAPPING; TRANS-ACTIVATORS;

EID: 13444261395     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh292     Document Type: Article

References (53)

1. Sugimura,T. (2000) Nutrition and dietary carcinogens. Carcinogenesis, 21, 387-395.
2. Kotake,K., Honjo,S., Sugihara,K., Kato,T., Kodaira,S., Takahashi,T., Yasutomi,M., Muto,T. and Koyama,Y. (2003) Changes in colorectal cancer during a 20-year period: an extended report from the multi-institutional registry of large bowel cancer, Japan. Dis. Colon Rectum, 46 (10 suppl.), 532-543.
3. Tamakoshi,K., Tokudome,S., Kuriki,K., Takekuma,K. and Toyoshima,H. (2001) Epidemiology and primary prevention of colorectal cancer (in Japanese). Jpn. J. Cancer Chemother., 28, 146-150.
4. Nagao,M. (1999) A new approach to risk estimation of food-borne carcinogens-heterocyclic amines-based on molecular information. Mutat. Res., 431, 3-12.
5. Sugimura,T. (1997) Overview of carcinogenic heterocyclic amines. Mutat. Res., 376, 211-219.
6. Ohgaki H. (2000) 7.1 Rodents. In Nagao,M. and Sugimura,T. (eds), Food Borne Carcinogens: Heterocyclic Amines. John Wiley & Sons, Ltd, New York, NY, pp. 198-228.
7. Weisburger,J.H. (2002) Comments on the history and importance of aromatic and heterocyclic amines in public health. Mutat. Res., 506/507, 9-20.
8. Wakabayashi,K., Nagao,M., Esumi,H. and Sugimura,T. (1992) Food-derived mutagens and carcinogens. Cancer Res., 52 (suppl.), 2092s-2098s.
9. Gerhardsson de Verdier,M., Hagman,U., Peters,R.K., Steineck,G. and Overvik,E. (1991) Meat, cooking methods and colorectal cancer: a case-referent study in Stockholm. Int. J. Cancer, 49 520-525.
10. Sinha,R. and Rothman,N. (1997) Exposure assessment of heterocyclic amines (HCAs) in epidemiologic studies. Mutat. Res., 376, 195-202.
11. Sinha,R. and Norat,T. (2002) Meat Cooking and Cancer Risk, Volume 156. IARC Scientific Publications, IARC, Lyon, pp. 181-186.
12. Wakabayashi,K., Ushiyama,H., Takahashi,M., Nukaya,H., Kim,S.B., Hirose,M., Ochiai,M., Sugimura,T. and Nagao, M. (1993) Exposure to heterocyclic amines. Environ. Health Perspect., 99, 129-134.
13. Bird,R.P. (1987) Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett., 37, 147-151.
14. Ochiai,M., Nakagama,H., Watanabe,M., Ishiguro,Y., Sugimura.T. and Nagao,M. (1996) Efficient method for rapid induction of aberrant crypt foci in rats with 2-amino-1-methyl-6-phenylimidazo[4,5-b pyridine. Jpn. J. Cancer Res., 87, 1029-1033.
15. Kristiansen,E. (1996) The role of aberrant crypt foci induced by the two heterocyclic amines 2-amino-3-methyl-imidazo[4,5-f quinoline (IQ) and 2-amino-1-methyl-6-phenyl-imidazo[4,5-b pyridine (PhIP) in the development of colon cancer in mice. Cancer Lett., 110, 187-192.
16. Ito,N., Hasegawa,R., Sano,M., Tamano,S., Esumi,H., Takayama,S. and Sugimura,T. (1991) A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis, 12, 1503-1506.
17. Ochiai,M., Imai,H., Sugimura,T., Nagao,M. and Nakagama,H. (2002) Induction of intestinal tumors and lymphomas in C57BL/6N mice by a food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine. Jpn. J. Cancer Res., 63, 478-483.
18. Fujita,H., Nagano,K., Ochiai,M., Ushijima,T., Sugimura,T., Nagao,M. and Mastushima,T. (1999) Difference in target organs in carcinogenicity of a heterocyclic amine, 2-amino-3,4-dimethylimidazo[4,5-f]quinoline, in different strains of mice. Jpn. J. Cancer Res., 90, 1203-1206.
19. Tanakamaru,Z., Mori,I., Nishikawa,A., Furukawa,F., Takahashi,M. and Mori,H. (2001) Essential similarities between spontaneous and MeIQx-promoted aberrant crypt foci in the F344 rat colon. Cancer Lett., 172, 143-149.
20. Okonogi,H., Ushijima,T., Shimizu,H., Sugimura,T. and Nagao,M. (1997) Induction of aberrant crypt foci in C57BL/6N mice by 2-amino-9H-pyrido[2,3-b]indole (AαC) and 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline (MeIQx). Cancer Lett., 111, 105-109.
21. Miller,J.R. and Moon,R.T. (1996) Signal transduction through β-catenin and specification of cell fate during embryogenesis. Genes Dev., 10, 2527-2539.
22. Kishida,S., Yamamoto,H., Ikeda,S., Kishida,M., Sakamoto,I., Koyama,S. and Kikuchi,A. (1998) Axin, a negative regulator of the wnt signaling pathway, directly interacts with adenomatous polyposis coli and regulates the stabilization of β-catenin. J. Biol. Chem., 273 10823-10826.
23. Dashwood,R.H., Suzui,M., Nakagama,H., Sugimura,T. and Nagao,M. (1998) High frequency of β-catenin (ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat. Cancer Res., 58, 1127-1129.
24. Suzui,M., Ushijima,T., Dashwood,R.H., Yoshimi,N., Sugimura,T., Mori,H. and Nagao,M. (1999) Frequent mutations of the rat β-catenin gene in colon cancers induced by methylazoxymethanol acetate plus 1-hydroxyanthraquinone. Mol Carcinogen., 24, 232-237.
25. Takahashi,M., Fukuda,K., Sugimura,T. and Wakabayashi,K. (1998) β-Catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res., 58, 42-46.
26. Takahashi,M., Nakatsugi,S., Sugimura,T. and Wakabayashi,K. (2000) Frequent mutations of the β-catenin gene in mouse colon tumors induced by azoxymethane. Carcinogenesis, 21, 1117-1120.
27. Morin,P.J., Sparks,A.B., Korinek,V., Barker,N., Clevers,H., Vogelstein,B. and Kinzler,K.W. (1997) Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275, 1787-1790.
28. Miyoshi,Y., Nagase,H., Ando,H., Horii,A., Ichii,S., Nakatsuru,S., Aoki,T., Miki,Y., Mori,T. and Nakamura,Y. (1992) Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum. Mol. Genet., 1, 229-233.
29. Powell,S.M., Zilz,N., Beazer-Barclay,Y., Bryan,T.M., Hamilton,S.R., Thibodeau,S.N., Vogelstein,B. and Kinzler,K.W. (1992) APC mutations occur early during colorectal tumorigenesis. Nature, 359, 235-237.
30. Sparks,A.B., Morin,P.J., Vogelstein,B. and Kinzler,K.W. (1998) Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res., 58, 1130-1134.
31. Iwamoto,M., Ahnen,D.J., Franklin,W.A. and Maltzman,T.H. (2000) Expression of β-catenin and full-length APC protein in normal and neoplastic colonic tissues. Carcinogenesis, 21, 1935-1940.
32. Tanaka,T., Kohno,H., Suzuki,R., Yamada,Y., Sugie,S. and Mori,H. (2003) A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci. 94, 965-973.
33. Ward,J.M. (1974) Morphogenesis of chemically induced neoplasms of the colon and small intestine in rats. Lab. Invest., 30, 505-513.
34. Nakagama,H., Ochiai,M., Ubagai,T., Tajima,R., Fujiwara,K., Sugimura,T. and Nagao,M. (2002) A rat colon cancer model induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, PhIP. Mutat. Res., 506-507, 137-144.
35. Tsukamoto,T., Tanaka,H., Fukami,H., Inoue,M., Takahashi,M., Wakabayashi,K. and Tatematsu,M. (2000) More frequent β-catenin gene mutations in adenomas than in aberrant crypt foci or adenocarcinomas in the large intestines of 2-amino-1-methyl-6-phenylimidazo[4,5-b pyridine (PhIP)-treated rats. Jpn. J. Cancer Res., 91, 792-796.
36. Ubagai,T., Ochiai,M., Kawamori,T., Imai,H., Sugimura,T., Nagao,M. and Nakagama,H. (2002) Efficient induction of rat large intestinal tumors with a new spectrum of mutations by intermittent administration of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in combination with a high fat diet. Carcinogenesis, 23, 197-200.
37. Ochiai,M., Ushigome,M., Fujiwara,K., Ubagai,T., Kawamori,T., Sugimura,T., Nagao,M. and Nakagama,H. (2003) Characterization of dysplastic aberrant crypt foci in the rat colon induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Am. J. Pathol. 163, 1607-1614.
38. Nakagama,H., Souda,K., Ochiai,M., Ishiguro,Y., Sugimura,T. and Nagao,M. (1999) Genetic analysis of the susceptibility in rats to aberrant crypt foci formation by 2-amino-1-methyl-6-phenylimidazo [4,5- b]pyridine, PhIP. Cancer Lett., 143, 205-209.
39. Nagaoka,H., Wakabayashi,K., Kim,S.B., Kim,I.S., Tanaka,Y., Ochiai,M., Tada,A., Nukaya,H., Sugimura,T. and Nagao,M. (1992) Adduct formation at C-8 of guanine on in vitro reaction of the ultimate form of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine with 2′-deoxyguanosine and its phosphate esters. Jpn. J. Cancer Res., 83, 1025-1029.
40. Koesters,R., Hans,M., Benner,A., Prosst,R., Boehm,J., Gahlen,J. and Doeberitz,M.K. (2001) Predominant mutation of codon 41 of the β-catenin proto-oncogene in rat colon tumors induced by 1,2-dimethylhydrazine using a complete carcinogenic protocol. Carcinogenesis, 22, 1885-1890.
41. Takabashi,M., Mutoh,M., Kawamori,T., Sugimura,T. and Wakabayashi,K. (2000) Altered expression of β-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis. Carcinogenesis, 21, 1319-1327.
42. Prescott,S.M. and White,R.L. (1996) Self-promotion? Intimate connections between APC and prostaglandin H synthase-2. Cell, 87 783-786.
43. Howe,L.R., Subbaramaiah,K., Chung,W.J., Dannenberg,A.J. and Brown,A.M. (1999) Transcriptional activation of cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells. Cancer Res., 59, 1572-1577.
44. Mei,J.M., Hord,N.G., Winterstein,D.F., Donald,S.P. and Phang,J.M. (1999) Differential expression of prostaglandin endoperoxide H synthase-2 and formation of activated β-catenin-LEF-1 transcription complex in mouse colonic epithelial cells contrasting in Apc. Carcinogenesis, 20, 737-740.
45. Tetsu,O. and McCormick,F. (1999) β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 398 422-426.
46. He,T.C., Sparks,A.B., Rago,C., Hermeking,H., Zawel,L., da Costa,L.T., Morin,P.J., Vogelstein,B. and Kinzler,K.W. (1998) Identification of c-MYC as a target of the APC pathway. Science, 281, 1509-1512.
47. Tanaka,T., Kohno,H., Shimada,R., Kagami,S., Yamaguchi,F., Kataoka,S., Ariga,T., Murakami,A., Koshimizu,K. and Ohigashi,H. (2000) Prevention of colonic aberrant crypt foci by dietary feeding of garcinol in male F344 rats. Carcinogenesis, 21, 1183-1189.
48. Rao,C.V., Indranie,C., Simi,B., Manning,P.T., Connor,J.R. and Reddy,B.S. (2002) Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Cancer Res., 62, 165-170.
49. Lala,P.K. and Chakraborty,C. (2001) Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol., 2, 149-156.
50. Seril,D.N., Liao,J., Ho,K.L., Yang,C.S. and Yang,G.Y. (2002) Inhibition of chronic ulcerative colitis-associated colorectal adenocarcinoma development in a murine model by N-acetylcysteine. Carcinogenesis, 23, 993-1001.
51. Mabley,J.G., Liaudet,L., Pacher,P., Southan,G.J., Salzman,A.L. and Szabo,C. (2002) Part II: beneficial effects of the peroxynitrite decomposition catalyst FP15 in murine models of arthritis and colitis. Mol. Med., 8, 581-590.
52. Suzuki,R., Kohno,H., Sugie,S. and Tanaka,T. (2004) Sequential observations on the occurrence of preneoplastic and neoplastic lesions in the mouse colon treated with azoxymethane and dextran sodium sulfate. Cancer Sci., 95, 721-727.
53. Ohshima, H. and Bartsch,H. (1994) Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res., 305, 253-264.